Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-ß-D-(6"-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay

Sousa, A P; Fernandes, D A; Ferreira, M D L; Cordeiro, L V; Souza, M F V; Pessoa, H L F; Oliveira Filho, A A; Sá, R C S.
Braz. j. biol ; 83: e244127, 2023. tab, graf
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1278526

Documentos relacionados

  1. Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-ß-D-(6"-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay.
  2. Safety evaluation of kaempferol glycosides-rich standardized roasted goji berry leaf extract.
  3. Subacute 28 days oral toxicity study of kaempferol and biochanin-A in the mouse model.
  4. Correlation of binding efficacies of DNA to flavonoids and their induced cellular damage.
  5. In vitro basal and metabolism-mediated cytotoxicity of flavonoids.
  6. [Chemical Constituents from Mitrasacme pygmaea].
  7. Comparative Analysis of Fluorescence Emission in Myricetin, Kaempferol, and Quercetin Powders and Solutions.
  8. Kaempferol inhibits airway inflammation induced by allergic asthma through NOX4-Mediated autophagy.
  9. Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6"-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay
  10. Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6"-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay